Skip to main content

Table 2 Model parameters

From: Cost-effectiveness of preemptive skin treatment to prevent skin-toxicity caused by panitumumab in third-line therapy for KRAS wild type metastatic colorectal cancer in Japan

Parameters

Base case

Standard error

95% Confidence interval

Time to skin-toxicity (Preemptive)

 Shape

1.851

0.216

1.427

2.275

 Scale

0.106

0.037

0.034

0.178

Time to skin-toxicity (Reactive)

 Shape

1.082

0.120

0.847

1.318

 Scale

0.379

0.084

0.215

0.543

Progression-free survival

 Shape

1.233

0.092

1.054

1.413

 Scale

0.137

0.029

0.081

0.194

Overall survival

 Shape

1.198

0.967

1.009

1.388

 Scale

0.479

0.143

0.020

0.076